EUVIMEDEUVIMED entdecken
Crossref

Ginkgo biloba Extract GBE50 ameliorates cerebrovascular dysfunction and cognitive impairment in a mouse model of Alzheimer's disease

Ting Yu, Zijie Wei, Jing Wang, Chenghuan Song, Wanying Huang, Pingao Zhang, Jiyun Shi, Rui Zhang, Meifang Jiang, Dandan Wang, Yongfang Zhang, Hongzhuan Chen und 1 weitere

Phytomedicine · 2025

DOI: 10.1016/j.phymed.2025.156646 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytomedicine, 2025. Verfasst von Ting Yu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Chemical Biology, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China; Department of Pharmacology…. Hauptthemen laut MEDLINE: Alzheimer Disease, Plant Extracts, Ginkgo biloba, Cognitive Dysfunction. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Shanghai Jiao Tong University, China Postdoctoral Science Foundation, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Alzheimer's disease (AD) is a complex neurodegenerative disorder in which neurovascular unit (NVU) dysfunction plays a critical role. GBE50, a refined extract of Ginkgo biloba containing over 50 % total flavonoids and terpene lactones, is widely used in the clinical prevention and treatment of cardiovascular and cerebrovascular diseases due to its anti-platelet aggregation, anti-inflammatory, and antioxidant properties. However, its specific effects on NVU integrity and cerebrovascular function in AD remain unclear. PURPOSE: This study aims to investigate the therapeutic effects of GBE50 on NVU integrity and cognitive impairment in an AD mouse model. METHODS: APP/PS1 transgenic mice were treated with GBE50 via intragastric administration for 10 weeks. Cognitive performance was assessed through behavioral tests, while the structural and functional integrity of the NVU was evaluated using immunofluorescence, laser speckle imaging, and in vivo multi-photon imaging. Furthermore, target prediction and transcriptomic analyses were conducted to uncover potential molecular mechanisms and identify specific targets of GBE50. RESULTS: GBE50 treatment significantly alleviated cognitive deficits in APP/PS1 mice. It enhanced cerebrovascular structure and function by increasing vessel density, diameter, and branching, leading to improved cerebral blood flow (CBF). GBE50 also restored NVU components such as endothelial cells, astrocytes, and pericytes, promoted parenchyma and perivascular Aβ clearance, and reduced neuroinflammation. Bioinformatics and transcriptomic analyses revealed that GBE50 exerted its effects by regulating pathways related to vascular repair, neuroprotection, and Aβ clearance. CONCLUSION: The findings demonstrate that GBE50 improves cognitive dysfunction in AD by restoring NVU integrity and cerebrovascular function through multi-target mechanisms. This study highlights the potential of GBE50 as a promising therapeutic approach for AD and other neurodegenerative diseases involved in cerebrovascular dysfunction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseasePlant ExtractsGinkgo bilobaCognitive DysfunctionCerebrovascular DisordersAnimalsMice, TransgenicMiceDisease Models, AnimalMaleMice, Inbred C57BLGinkgo Extract

Stichwörter der Autor:innen

Alzheimer's diseaseCerebral blood flowCerebrovascular functionGBE50Neurovascular unit

Substanzen

Plant ExtractsGinkgo biloba extractGinkgo Extract

Autor:innen und Institutionen

  • Department of Pharmacology and Chemical Biology, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China; Department of Pharmacology, School of Basic Medical Sciences and Forensic Medicine, Hangzhou Med…
  • Department of Pharmacology and Chemical Biology, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
  • Department of Pharmacology and Chemical Biology, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China; Academy of Integrative Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 2…
  • SPH XingLing Sci. & Tech. Pharmaceutical Co., Ltd., Shanghai 201203, China.
  • Department of Pharmacology and Chemical Biology, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China. Electronic address: 182430@shsmu.edu.cn.

Förderung

  • Shanghai Jiao Tong University
  • China Postdoctoral Science Foundation
  • National Natural Science Foundation of China

Zitieren

APA

Yu, T., Wei, Z., Wang, J., Song, C., Huang, W., Zhang, P., Shi, J., Zhang, R., Jiang, M., Wang, D., Zhang, Y., Chen, H., & Wang, H. (2025). Ginkgo biloba Extract GBE50 ameliorates cerebrovascular dysfunction and cognitive impairment in a mouse model of Alzheimer's disease. Phytomedicine. https://doi.org/10.1016/j.phymed.2025.156646

Vancouver

Yu T, Wei Z, Wang J, Song C, Huang W, Zhang P, et al. Ginkgo biloba Extract GBE50 ameliorates cerebrovascular dysfunction and cognitive impairment in a mouse model of Alzheimer's disease. Phytomedicine. 2025. doi:10.1016/j.phymed.2025.156646

BibTeX
@article{Yu2025,
  author = {Yu, Ting and Wei, Zijie and Wang, Jing and Song, Chenghuan and Huang, Wanying and Zhang, Pingao and Shi, Jiyun and Zhang, Rui and Jiang, Meifang and Wang, Dandan and Zhang, Yongfang and Chen, Hongzhuan and Wang, Hao},
  title = {Ginkgo biloba Extract GBE50 ameliorates cerebrovascular dysfunction and cognitive impairment in a mouse model of Alzheimer's disease},
  journal = {Phytomedicine},
  year = {2025},
  doi = {10.1016/j.phymed.2025.156646}
}
Kostenlos starten →